Consolidation Immunotherapy in Unresectable Early NSCLC: Nov

Sandip Patel, MD, shares his expert perspectives on novel combination consolidation immunotherapy regimens that are under evaluation in unresectable early-stage NSCLC.

Related Keywords

Sandip Patel , , Recent Updates , Translating Evidence , Clinical Practice , Unresectable Early , Nsclc , Early Nsclc , Non Small Cell Lung Cancer , Asco 2023 , Localized Disease , Presection , Surgery , Staging , Chemoimmunotherapy , Immunotherapy , Ohio , Molecular Testing , Liquid Biopsy , Tissue Biopsy , Ngs Testing , Egfr , Talk ,